Correlation Between Histogram-based DCE-MRI Parameters and 18F-FDG PET Values in Oropharyngeal Squamous Cell Carcinoma: Evaluation in Primary Tumors and Metastatic Nodes

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Mar 3

PMID 32119697

Citations 4

Authors

Antonello Vidiri

Emma Gangemi

Emanuela Ruberto

Rosella Pasqualoni

Rosa Sciuto

Giuseppe Sanguineti

Alessia Farneti

Maria Benevolo

Francesca Rollo

Francesca Sperati

Filomena Spasiano

Raul Pellini

Simona Marzi

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the correlation between histogram-based Dynamic Contrast-Enhanced magnetic resonance imaging (DCE-MRI) parameters and positron emission tomography with 18F-fluorodeoxyglucose (18F-FDG-PET) values in oropharyngeal squamous cell carcinoma (OPSCC), both in primary tumors (PTs) and in metastatic lymph nodes (LNs).

Methods: 52 patients with a new pathologically-confirmed OPSCC were included in the present retrospective cohort study. Imaging including DCE-MRI and 18F-FDG PET/CT scans were acquired in all patients. Both PTs and the largest LN, if present, were volumetrically contoured. Quantitative parameters, including the transfer constants, Ktrans and Kep, and the volume of extravascular extracellular space, ve, were calculated from DCE-MRI. The percentiles (P), P10, P25, P50, P75, P90, and skewness, kurtosis and entropy were obtained from the histogram-based analysis of each perfusion parameter. Standardized uptake values (SUV), SUVmax, SUVpeak, SUVmean, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were calculated applying a SUV threshold of 40%. The correlations between all variables were investigated with the Spearman-rank correlation test. To exclude false positive results under multiple testing, the Benjamini-Hockberg procedure was applied.

Results: No significant correlations were found between any parameters in PTs, while significant associations emerged between Ktrans and 18F-FDG PET parameters in LNs.

Conclusions: Evident relationships emerged between DCE-MRI and 18F-FDG PET parameters in OPSCC LNs, while no association was found in PTs. The complex relationships between perfusion and metabolic biomarkers should be interpreted separately for primary tumors and lymph-nodes. A multiparametric approach to analyze PTs and LNs before treatment is advisable in head and neck squamous cell carcinoma (HNSCC).

Citing Articles

MRI for Differentiation between HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Chen L, Lauwers I, Verduijn G, Philippens M, Gahrmann R, Capala M Cancers (Basel). 2024; 16(11).

PMID: 38893224 PMC: 11171338. DOI: 10.3390/cancers16112105.

Prediction of pathological complete response in locally advanced head and neck squamous cell carcinoma treated with neoadjuvant chemo-immunotherapy using volumetric multisequence MRI histogram analysis.

Liu H, Zhu C, Wang X, Chen X, Li Z, Xian J Neuroradiology. 2024; 66(6):919-929.

PMID: 38503986 DOI: 10.1007/s00234-024-03339-6.

Multiparametric MRI Evaluation of Oropharyngeal Squamous Cell Carcinoma. A Mono-Institutional Study.

Piludu F, Marzi S, Gangemi E, Farneti A, Marucci L, Venuti A J Clin Med. 2021; 10(17).

PMID: 34501313 PMC: 8432241. DOI: 10.3390/jcm10173865.

Application of Community Detection Algorithm to Investigate the Correlation between Imaging Biomarkers of Tumor Metabolism, Hypoxia, Cellularity, and Perfusion for Precision Radiotherapy in Head and Neck Squamous Cell Carcinomas.

Paudyal R, Grkovski M, Oh J, Schoder H, Aramburu Nunez D, Hatzoglou V Cancers (Basel). 2021; 13(15).

PMID: 34359810 PMC: 8345739. DOI: 10.3390/cancers13153908.

References

Norikane T, Yamamoto Y, Maeda Y, Kudomi N, Matsunaga T, Haba R . Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET. Nucl Med Commun. 2013; 35(1):30-5. DOI: 10.1097/MNM.0000000000000010. View

Kroenke M, Hirata K, Gafita A, Watanabe S, Okamoto S, Magota K . Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer. PLoS One. 2019; 14(2):e0213111. PMC: 6394953. DOI: 10.1371/journal.pone.0213111. View

Shen G, Ma H, Liu B, Ren P, Kuang A . Correlation of the apparent diffusion coefficient and the standardized uptake value in neoplastic lesions: a meta-analysis. Nucl Med Commun. 2017; 38(12):1076-1084. DOI: 10.1097/MNM.0000000000000746. View

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

Surov A, Meyer H, Wienke A . Can Imaging Parameters Provide Information Regarding Histopathology in Head and Neck Squamous Cell Carcinoma? A Meta-Analysis. Transl Oncol. 2018; 11(2):498-503. PMC: 5884190. DOI: 10.1016/j.tranon.2018.02.004. View

Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B . Double positivity for HPV-DNA/p16 is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients. Oral Oncol. 2018; 78:137-144. DOI: 10.1016/j.oraloncology.2018.01.010. View

Swartz J, Pothen A, Stegeman I, Willems S, Grolman W . Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review. Cancer Med. 2015; 4(7):1101-16. PMC: 4529348. DOI: 10.1002/cam4.460. View

Surov A, Meyer H, Hohn A, Wienke A, Sabri O, Purz S . F-FDG-PET Can Predict Microvessel Density in Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2019; 11(4). PMC: 6521262. DOI: 10.3390/cancers11040543. View

Gawlitza M, Purz S, Kubiessa K, Boehm A, Barthel H, Kluge R . In Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRI. PLoS One. 2015; 10(8):e0134749. PMC: 4536035. DOI: 10.1371/journal.pone.0134749. View

10.

Meyer H, Leifels L, Hamerla G, Hohn A, Surov A . Associations between Histogram Analysis Parameters Derived from DCE-MRI and Histopathological Features including Expression of EGFR, p16, VEGF, Hif1-alpha, and p53 in HNSCC. Contrast Media Mol Imaging. 2019; 2019:5081909. PMC: 6334376. DOI: 10.1155/2019/5081909. View

11.

Bonomo P, Merlotti A, Olmetto E, Bianchi A, Desideri I, Bacigalupo A . What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2018; 45(12):2122-2138. PMC: 6182396. DOI: 10.1007/s00259-018-4065-5. View

12.

Fischbein N, Noworolski S, Henry R, Kaplan M, Dillon W, Nelson S . Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2003; 24(3):301-11. PMC: 7973604. View

13.

Covello M, Cavaliere C, Aiello M, Cianelli M, Mesolella M, Iorio B . Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation. Eur J Radiol. 2015; 84(7):1269-76. DOI: 10.1016/j.ejrad.2015.04.010. View

14.

Jacob R, Welkoborsky H, Mann W, Jauch M, Amedee R . [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. ORL J Otorhinolaryngol Relat Spec. 2001; 63(5):307-13. DOI: 10.1159/000055764. View

15.

Incoronato M, Grimaldi A, Cavaliere C, Inglese M, Mirabelli P, Monti S . Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study. Eur J Nucl Med Mol Imaging. 2018; 45(10):1680-1693. DOI: 10.1007/s00259-018-4010-7. View

16.

Bisdas S, Seitz O, Middendorp M, Chambron-Pinho N, Bisdas T, Vogl T . An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer. Eur Radiol. 2010; 20(10):2358-66. DOI: 10.1007/s00330-010-1803-x. View

17.

Surov A, Meyer H, Hohn A, Sabri O, Purz S . Combined Metabolo-Volumetric Parameters of F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot Study. Transl Oncol. 2018; 12(1):8-14. PMC: 6143720. DOI: 10.1016/j.tranon.2018.08.018. View

18.

Joo Y, Yoo I, Cho K, Park J, Nam I, Kim M . Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma. Head Neck. 2013; 36(3):323-7. DOI: 10.1002/hed.23296. View

19.

Rasmussen G, Vogelius I, Rasmussen J, Schumaker L, Ioffe O, Cullen K . Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma. Acta Oncol. 2015; 54(9):1408-15. DOI: 10.3109/0284186X.2015.1062539. View

20.

Lee N, Schoder H, Beattie B, Lanning R, Riaz N, McBride S . Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2016; 96(1):9-17. PMC: 5035649. DOI: 10.1016/j.ijrobp.2016.04.027. View